from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3249c/-

LFCtreatmentdescriptionclass of inhibitor

0.453

Amikacinug/mL Amikacintranslation

-0.137

Cap5-10ug/mL Capreomycintranslation

0.744

Rox10-50 ug/mL Roxithromycintranslation

1.412

SM2-5 ug/mL Streptomycintranslation

0.630

Tet5-10 ug/mL Tetracyclinetranslation

-0.297

Rif0.2-5ug/mL Rifampicintranscription

0.190

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.022

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.129

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.161

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.011

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.062

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.997

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.005

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.305

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.328

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.918

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.207

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.663

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.055

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.636

KCN5-20 ug/mL Potassium cyaniderespiration

-0.286

NaN30.2-2 mM Sodium aziderespiration

-0.267

Nigericin50 uM Nigericinrespiration

1.518

TRC10-150 ug/mL Triclosanrespiration

-0.216

TRZ10-25 ug/mL Thioridazinerespiration

1.048

Valinomycin0.5-10 uM Valinomycinrespiration

0.019

ZnSO42 mM ZnSO4respiration

-0.861

menadione6-10 ug/mL Menadionerespiration

1.932

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.231

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.789

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.137

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.080

NRP_1Non-replicating persistence stage 1dosRassociated

-0.182

Amp0.2mg/mL AmpicillincellWall

-0.338

Cephalexin20-100 ug/mL CephalexincellWall

-0.007

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.783

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.122

EMB10-20 ug/mL EthambutolcellWall

-0.148

Eta12-40 ug/mL EthionamidecellWall

-0.557

INH0.2-0.4 ug/mL IsoniazidcellWall

0.370

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.223

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.027

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.540

BZA0.12 mg/mL BenzamidearomaticAmides

0.233

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.633

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.887

H2O24 mM hydrogen peroxideDNAdamaging

-0.232

Levo10 ug/mL LevofloxacinDNAdamaging

-0.590

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.980

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.034

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.910

UVUV-irradiationDNAdamaging

0.317

ARP41-4 ug/mL Antitubercular compound ARP4?

0.209

Antimycin12.5-50 ug/mL Antimycin A?

-0.353

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.257

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.252

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.835

PA8240.2-2 ug/mL PA-824?

-1.264

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.488

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.462

Verapamil50 uM Verapamil?

0.721

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.114

methoxatin10-20 ug/mL Methoxatin?